Bluebird bio, which has been facing a cash crunch, first raised going-concern doubts three years ago. It laid off a quarter of its workforce last year to focus on launching three gene therapies, ...
2d
International travelers already appear to be pulling back on travel to the U.S., including from the United States' top source ...
The ASX 200's upbeat mood didn't last long. The index has slipped after a tech rout on Wall Street. Trump tariffs are also ...
The moves are in violation of the US' obligations under the General Agreement on Tariffs and Trade 1994 of the WTO. The ...
The big difference with Trump’s tariffs is that it is virtually impossible to predict their economic impact, since the size ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback